MFOHome About Commentary Discussions Funds The Best Resources Support Us!

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Sign In Register

Categories

In this Discussion

  • Art August 2013
  • ron August 2013
  • Sven August 2013
  • Ted August 2013
Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Fund Focus: Fidelity Select Biotechnology Fund : FBIOX

Comments

  • Sven
    Thanks Ted. Do you think this is a viable alternative to T. Rowe Price Health Science, PRHSX today?

  • ron
    I had owned an ETF, IBB for a few years, sold last year. Did very well.
  • Sven
    Reply to @ron: Thanks. Will check it out.
  • TedTed
    Reply to @Sven: I like FBIOX, and yes it's a viable alternative to PRHSX. Also, look at HQH, HQL, DLHAX, PHSZX.
    Regards,
    Ted
  • Sven
    Reply to @Ted: Thank you. Look like I have more homework to do.
  • Art
    Reply to @Sven:

    If this is a long term hold at Fidelity you might also consider (FSPHX). At this time (FSPHX) has a 25% overlap with (FBIOX).

    Art
  • Sven
    Reply to @Art: My only reservation on Fidelity's sector funds is that they are the training ground for new fund managers. Vanguard Health Care, VGHAX and T.Rowe Price Health Care, PRSHX have had stable management team until Jenner moved on. Today, biotechnology is contributing more than half of today's blockbuster medicine.
Sign In or Register to comment.